Nation’s Largest Marijuana Policy Reform Group Releases Report on Cannabis Vaping Regulations
Read MPP’s report, which includes recommendations for regulating cannabis vaping products, at www.mpp.org/VapingReport
WASHINGTON, D.C., Oct 02, 2019 — In the recent wake of vaping-related illnesses and fatalities, the Marijuana Policy Project has released a report, titled Regulating Cannabis Oil Vaporizers, that examines the issue and provides recommendations for policymakers who wish to respond. While the uprise in these incidents is largely attributed to unregulated and untested cannabis oil vaping products obtained through the illicit market, they raise serious concerns that must be addressed.
MPP’s report discusses current state-level regulatory controls on vaping products and provides short-, medium-, and long-term recommendations that policymakers can implement to further protect cannabis consumers. The conclusion of the report calls on the federal government to take a comprehensive approach to product safety testing that can come with legalization at the federal level.
Read the full report here: www.mpp.org/VapingReport
Importantly, the Marijuana Policy Project believes that banning regulated and tested products is a short-sighted and harmful approach that will drive a significant number of consumers to illicit products, where the health concerns actually originate.
The recent issues associated with vaping cannabis oil raise serious concern for consumers and emphasize why it is increasingly important to legalize and regulate cannabis. Unregulated markets are producing unregulated products, which are proving to be detrimental to public health.
Statement from Steve Hawkins, executive director at the Marijuana Policy Project
Consumers who choose to responsibly consume cannabis deserve to know that the products they are using are tested and safe. This is only possible through legal and regulated markets.
Statement from Chris Lindsey, director of government relations at the Marijuana Policy Project:
“A regulatory approach to cannabis use is good policy, and we now have a framework for controlling cannabis products in many parts of the country. These illnesses are a tragedy, but they are also a chance for cannabis programs to increase their effectiveness even more. The recommendations we offer are aimed at doing just that.”
